PubRank

D Guerry

Author PubWeight™ 90.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989 5.28
2 A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984 3.21
3 Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 1997 2.65
4 Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med 1985 2.54
5 Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med 1991 1.95
6 Optimal resection margin for cutaneous malignant melanoma. Plast Reconstr Surg 1983 1.89
7 Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 1985 1.85
8 Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase. Ann Surg Oncol 2000 1.74
9 The dysplastic nevus syndrome: our definition. Am J Dermatopathol 1982 1.63
10 A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group. Ann Intern Med 1996 1.62
11 Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study Group. Cancer 1997 1.57
12 Action spectrum for retinal injury from near-ultraviolet radiation in the aphakic monkey. Am J Ophthalmol 1982 1.56
13 A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med 1977 1.51
14 Observations on Cogan's microcystic dystrophy of the corneal epithelium. Trans Am Ophthalmol Soc 1965 1.35
15 The nature of retinal radiation damage: dependence on wavelength, power level and exposure time. Vision Res 1980 1.33
16 Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J Natl Cancer Inst 1985 1.30
17 Proliferation, differentiation, and cytogenetics of chronic leukemic B lymphocytes cultured with mitomycin-treated normal cells. Blood 1981 1.25
18 Basic mechanisms underlying the production of photochemical lesions in the mammalian retina. Curr Eye Res 1984 1.21
19 Periodic hematopoiesis in human cyclic neutropenia. J Clin Invest 1973 1.15
20 Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet Cytogenet 1984 1.15
21 Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma. Cancer Epidemiol Biomarkers Prev 2001 1.14
22 Progression-related expression of beta3 integrin in melanomas and nevi. Hum Pathol 1999 1.13
23 Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. Lancet 1980 1.12
24 Invasive malignant melanomas lacking competence for metastasis. Am J Dermatopathol 1984 1.11
25 WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma. J Clin Oncol 1987 1.06
26 Congenital orbital teratoma. Arch Ophthalmol 1974 1.06
27 The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi. Semin Diagn Pathol 1993 1.03
28 Risk of melanoma and other cancers in melanoma-prone families. J Invest Dermatol 1993 1.02
29 Dysplastic naevi and cutaneous melanoma risk. Lancet 1983 0.99
30 Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells. J Immunol 1985 0.98
31 CD4(+), HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells. Int J Cancer 2000 0.98
32 HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes. J Clin Invest 1984 0.97
33 Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol 1990 0.97
34 Concanavalin A-mediated binding and sphering of human red blood cells by homologous monocytes. J Exp Med 1976 0.96
35 Cytogenetic evidence for the clonal nature of Richter's syndrome. Blood 1981 0.93
36 Chronic neutropenia. Medicine (Baltimore) 1979 0.93
37 Effect of cytochalasin B on human monocyte binding and sphering of IgG-coated human erythrocytes. Blood 1977 0.92
38 Chromosome 10 allelic loss in malignant melanoma. Genes Chromosomes Cancer 1993 0.91
39 Characterization of tenascin secreted by human melanoma cells. Cancer Res 1991 0.91
40 Malignant angioendotheliomatosis proliferans treated with doxorubicin. Arch Dermatol 1982 0.91
41 Effects of topical tretinoin on dysplastic nevi. J Clin Oncol 1994 0.91
42 Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Arch Dermatol 1991 0.90
43 Production of multiple cytokines by cultured human melanomas. Exp Dermatol 1993 0.89
44 Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma. J Immunol 1987 0.89
45 Production of interleukin 1 activity by cultured human melanoma cells. Cancer Res 1989 0.89
46 A cohort study of melanoma in patients with dysplastic nevi. J Invest Dermatol 1993 0.89
47 Natural history of dysplastic nevi. J Am Acad Dermatol 1993 0.89
48 Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer 1994 0.88
49 Locally recurrent malignant melanoma characteristics and outcomes: a single-institution study. Ann Plast Surg 2001 0.88
50 The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51-3.99 mm). Cancer 1985 0.88
51 MR imaging of intracranial metastatic melanoma. J Comput Assist Tomogr 1987 0.87
52 Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease. J Immunol 1989 0.87
53 Lack of association between intraocular melanoma and cutaneous dysplastic nevi. Am J Ophthalmol 1984 0.84
54 Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variation. Cancer Epidemiol Biomarkers Prev 1995 0.83
55 Neoplastic progression and prognosis in melanoma. Semin Cutan Med Surg 1996 0.82
56 Experiences with Light Coagulation of Fundus Lesions. Trans Am Ophthalmol Soc 1959 0.81
57 Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracil. Arch Dermatol 1981 0.81
58 Patient and physician delay in melanoma diagnosis. J Am Acad Dermatol 1988 0.81
59 Phenotypic characteristics of cells derived from precursors of human melanoma. Cancer Res 1983 0.81
60 Ischemic colitis associated with factor V Leiden mutation. Ann Intern Med 2000 0.81
61 Chromosome 9 deletion in sporadic and familial melanomas in vivo. Oncogene 1994 0.81
62 Managing the dysplastic naevus syndrome. Lancet 1984 0.80
63 Melanuria. Acta Cytol 1986 0.80
64 Immunoassay for melanoma-associated proteoglycan in the sera of patients using monoclonal and polyclonal antibodies. Cancer Res 1984 0.80
65 Changes in membrane markers and chromosome patterns in chronic T-cell leukemia. Clin Immunol Immunopathol 1979 0.80
66 Increased levels of circulating HLA-DR antigen in sera of patients with acute lymphoblastoid leukemia. Leuk Res 1984 0.79
67 Granulocyte-associated IgG in neutropenic disorders. Blood 1982 0.79
68 Human cutaneous nevi transplanted onto nude mice: a model for the study of the lesional steps in tumor progression. Cancer Res 1986 0.78
69 Loco-regional nodal relapse in melanoma. Surg Oncol 1992 0.77
70 Observations on Cogan's microcystic dystrophy of the corneal epithelium. Am J Ophthalmol 1966 0.77
71 Adenoviral transduction of melanoma cells with B7-1: antitumor immunity and immunosuppressive factors. Cancer Immunol Immunother 1998 0.77
72 B lymphocyte expression of a recognition locus for human monocytes and macrophages. J Immunol 1978 0.77
73 Levels of disialogangliosides in sera of melanoma patients monitored by sensitive thin-layer chromatography and immunostaining. J Natl Cancer Inst 1989 0.77
74 Effects of laser radiation on the mammalian eye. Trans N Y Acad Sci 1966 0.76
75 Human cyclic neutropenia: urinary colony-stimulating factor and erythropoietin levels. Blood 1974 0.76
76 Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma. Invest New Drugs 1987 0.75
77 Disseminated melanoma--is there a new standard therapy? N Engl J Med 1992 0.75
78 Melanoma and other skin neoplasms. Curr Opin Oncol 1995 0.75
79 Curable melanomas: seek, and ye shall find. J Gen Intern Med 1993 0.75
80 Bilateral choroidal detachment and fluctuating proptosis secondary to bilateral dural arteriovenous fistulas treated with transcranial orbital decompression with resolution: report of a case. Trans Am Ophthalmol Soc 1975 0.75
81 Human monocyte-lymphocyte interaction and its enhancement by levamisole. Clin Exp Immunol 1979 0.75
82 Dural arteriovenous fistula and spontaneous choroidal detachment: new cause of an old disease. Br J Ophthalmol 1978 0.75
83 A study of the comparative effects of ionizing radiation and aging on the mammalian lens of the eye. Health Phys 1967 0.75
84 Description of Recession Forceps. Trans Am Ophthalmol Soc 1959 0.75
85 Melanoma and other skin neoplasms. Commentary. Curr Opin Oncol 1994 0.75
86 Skin markings in malignant melanoma. JAMA 1983 0.75
87 Functional consequence of variation in melanoma antigen expression. Cancer Immunol Immunother 1983 0.75
88 Radiation-induced chromatid breaks and DNA repair in blood lymphocytes of patients with dysplastic nevi and/or cutaneous melanoma. J Invest Dermatol 1997 0.75
89 "Catalyst" symptoms in malignant melanoma. J Gen Intern Med 1987 0.75
90 Light coagulation. Va Med Mon (1918) 1968 0.75
91 For the record: the history of precursors to malignant melanoma. Arch Dermatol 1984 0.75
92 The Use of the Sanborn Electromanometer in the Study of Pharmacological Effects upon the Intraocular Pressure. Trans Am Ophthalmol Soc 1951 0.75
93 Target blue nevus. Arch Dermatol 1983 0.75
94 Factor XII deficiency with systemic lupus erythematosus. Biological implications. Arthritis Rheum 1979 0.75
95 Black cornea secondary to topical epinephrine. Am J Ophthalmol 1971 0.75
96 Gene therapy for melanoma in humans. Hematol Oncol Clin North Am 1998 0.75
97 Neutrophil-releasing activity in plasma of normal human subjects injected with etiocholanolone (39904). Proc Soc Exp Biol Med 1977 0.75
98 Opportunistic pathogens in the immunologically hyperresponsive host. Pneumocystic carinii infection in a patient with allergic bronchopulmonary aspergillosis. Am J Med 1973 0.75
99 Obituary. George Nelms Wise, MD 1915 - 1974. Arch Ophthalmol 1975 0.75
100 On the definition of the aqueous veins. Am J Ophthalmol 1968 0.75
101 Biomicroscopic characteristics of the aqueous veins. Eye Ear Nose Throat Mon 1969 0.75
102 On widths of margins in excision of primary malignant melanomas. Ethics of randomized trials of wide and narrow margins. Am J Dermatopathol 1984 0.75